Substitution treatment of injecting opioid users for prevention of HIV infection.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2004-10-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD004145.PUB2PMID 15495080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.

  2005cited by this paper
• Methadone treatment and risk of HIV infection in drug users without legal access to clean injection equipment

  2005cited by this paper
• Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.

  2005cited by this paper
• Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

  2005cited by this paper
• Risk Factors and Predictors of Human Immunodeficiency Virus Infection among Injection Drug Users

  2005cited by this paper
• Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.

  2004cited by this paper
• Drug injection cessation among HIV-infected injecting drug users.

  2004cited by this paper
• [Opioid-related disorders].

  2003cited by this paper
• Prevalencia de infección por virus de la inmunodeficiencia humana y hepatitis C en una cohorte de pacientes en tratamiento de mantenimiento con metadona

  2003cited by this paper
• A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.

  2003cited by this paper
• Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users.

  2003cited by this paper
• The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results.

  2003cited by this paper
• A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.

  2003cited by this paper
• Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up.

  2003cited by this paper
• Reduced injection risk and sexual risk behaviours after drug misuse treatment: Results from the National Treatment Outcome Research Study

  2002cited by this paper
• Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

  2002cited by this paper
• Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

  2002cited by this paper
• Modelling drug use: methods to quantify and understand hidden processes.

  2001cited by this paper
• Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.

  2001cited by this paper
• Methadone maintenance as HIV risk reduction with street-recruited injecting drug users.

  2001cited by this paper
• Prescribing drug of choice to opiate dependent drug users: a comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic

  2001cited by this paper
• ABC of Aids: Development of the epidemic.

  2001cited by this paper
• Heroin use and HIV risk-taking behaviour among women injecting drug users

  2001cited by this paper
• Methadone Maintenance as HIV Risk Reduction With Street‐Recruited Injecting Drug Users

  2001cited by this paper
• INFECTIOUS DISEASES AND PUBLIC HEALTH: RISK-TAKING BEHAVIOR DURING PARTICIPATION IN THE SWISS PROGRAM FOR A MEDICAL PRESCRIPTION OF NARCOTICS (PROVE)

  2001cited by this paper
• Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study.

  2000cited by this paper
• Methadone‐Related Opioid Agonist Pharmacotherapy for Heroin Addiction: History, Recent Molecular and Neurochemical Research and Future in Mainstream Medicine

  2000cited by this paper
• Trends in HIV risk behaviour and methadone dosage among HIV-negative drug users: an ecological study.

  2000cited by this paper
• Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study.

  2000cited by this paper
• Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area

  2000cited by this paper
• Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial.

  2000cited by this paper
• HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

  2000cited by this paper
• Influence of Psychiatric Comorbidity on HIV Risk Behaviors

  2000cited by this paper
• Randomized trial of supervised injectable versus oral methadone maintenance: report of feasibility and 6-month outcome.

  2000cited by this paper
• Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs

  2000cited by this paper
• Sex, Drugs, and HIV: Does Methadone Maintenance Reduce Drug Use and Risky Sexual Behavior?

  2000cited by this paper
• Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study.

  1999cited by this paper
• Reduced infections with HIV and hepatitis A during a Swiss intravenous opiate maintenance program.

  1999cited by this paper
• HIV risk reduction in outpatient drug abuse treatment: individual and geographic differences.

  1999cited by this paper
• Comparing Opiate Users in Methadone Treatment with Untreated Opiate Users: Results of a Follow-up Study with a Toronto Opiate User Cohort

  1999cited by this paper
• Methadone maintenance treatment: outcomes from the Otago methadone programme.

  1999cited by this paper
• Retrospective analyses of additional services for methadone maintenance patients.

  1999cited by this paper
• Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study.

  1999cited by this paper
• Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.

  1999cited by this paper
• Gender differences at admission and follow-up in a sample of methadone maintenance clients.

  1999cited by this paper
• Advances in the medical management of patients with HIV-1 infection: an overview.

  1999cited by this paper
• AIDS risk behavior in opioid dependent patients treated with community reinforcement approach and relationships with psychiatric disorders.

  1998cited by this paper
• Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison.

  1998cited by this paper
• Changes in HIV risk behaviors among cocaine-using methadone patients.

  1998cited by this paper
• Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.

  1998cited by this paper
• Methadone maintenance treatment reduces heroin injection in New South Wales prisons.

  1998cited by this paper
• Drug abuse treatment as HIV prevention: changes in social drug use patterns might also reduce risk.

  1998cited by this paper
• Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.

  1998cited by this paper
• Community reinforcement approach in the treatment of opiate addicts.

  1998cited by this paper
• Feasibility of prescribing injectable heroin and methadone to opiate‐dependent drug users: associated health gains and harm reductions

  1998cited by this paper
• Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian.

  1998cited by this paper
• HIV infection risks, behaviors and methadone treatment: client-reported HIV infection in a follow-up study of injecting drug users in New England.

  1997cited by this paper
• A Morphine Prescription Program in Italy (1980-1985): Retrospective Evidence of Protection Against Hiv/Aids

  1997cited by this paper
• Factors associated with client-reported HIV infection among clients entering methadone treatment.

  1997cited by this paper
• Outcomes of Methadone Maintenance 1 Year after Admission

  1997cited by this paper
• Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up.

  1997cited by this paper
• History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.

  1997cited by this paper
• Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease.

  1997cited by this paper
• Changes in HIV/AIDS Risk Behaviors in Drug Users in St. Louis: Applications of Random Regression Models

  1997cited by this paper
• Sex, drugs and HIV counseling and testing: a prospective study of behavior‐change among methadone‐maintenance clients in New England

  1997cited by this paper
• Retention in methadone maintenance is associated with reductions in different HIV risk behaviors for women and men.

  1996cited by this paper
• Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance.

  1996cited by this paper
• Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens.

  1996cited by this paper
• Changes in HIV risk behavior among injecting drug users: the impact of 21 versus 90 days of methadone detoxification

  1996cited by this paper
• HIV risk behaviors among women in methadone maintenance treatment.

  1996cited by this paper
• What happens when a demonstration project ends. Consequences for a clinic and its clients.

  1996cited by this paper
• Patterns of Heroin, Cocaine and Speedball Injection Among Bronx (Usa) Methadone Maintenance Patients: 1978-1988

  1996cited by this paper
• Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use.

  1996cited by this paper
• Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.

  1996cited by this paper
• Methadone maintenance and the likelihood of risky needle-sharing.

  1995cited by this paper
• HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment.

  1995cited by this paper
• Ethnic differences in HIV risk behaviors, self-perceptions, and treatment outcomes among women in methadone maintenance treatment.

  1995cited by this paper
• The relationship of counselor and peer alliance to drug use and HIV risk behaviors in a six-month methadone detoxification program.

  1995cited by this paper
• Risk factors for HIV-1 seroconversion among injection drug users: a case-control study.

  1995cited by this paper
• Client engagement and change during drug abuse treatment.

  1995cited by this paper
• The introduction of a methadone prescribing programme to a drug-free treatment service: implications for harm reduction.

  1995cited by this paper
• Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction.

  1995cited by this paper
• A LOW-THRESHOLD METHADONE STABILIZATION PROGRAM - DESCRIPTION AND FIRST STAGE EVALUATION

  1995cited by this paper
• Client engagement and change during drug abuse treatment

  1995cited by this paper
• AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic.

  1995cited by this paper
• Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors.

  1995cited by this paper
• HIV seroconversion in intravenous drug users in San Francisco, 1985–1990

  1994cited by this paper
• Longitudinal changes in injection behaviors in a cohort of injection drug users.

  1994cited by this paper
• Changing Needle Practices in Community Outreach and Methadone Treatment

  1994cited by this paper
• Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.

  1994cited by this paper
• THE PRIVATIZATION OF METHADONE MAINTENANCE; CHANGES IN RISK BEHAVIOR ASSOCIATED WITH COST RELATED DETOXIFICATION

  1994cited by this paper
• Medical care for injection-drug users with human immunodeficiency virus infection.

  1994cited by this paper
• Reducing HIV risk behavior among injection drug users: effect of methadone maintenance treatment on number of sex partners.

  1994cited by this paper
• HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.

  1994cited by this paper
• Reduction of AIDS risk among 41 heroin addicted female street prostitutes: effects of free methadone maintenance.

  1993cited by this paper
• Correlates of drug injection behaviors among methadone outpatients.

  1993cited by this paper
• Antisocial personality disorder and HIV infection among intravenous drug abusers.

  1993cited by this paper
• Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.

  1993cited by this paper
• Methadone maintenance and needle/syringe sharing.

  1993cited by this paper
• [HIV prevention in HIV-positive drug addicts. A methadone-supported model].

  1993cited by this paper

• Characterizing Opioid Withdrawal Experiences and Consequences Among a Community Sample of People Who Use Opioids

  2024cites this paper
• Risk of infections among persons treated with opioids for chronic pain: a systematic review and meta-analysis protocol

  2024cites this paper
• Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland.

  2023cites this paper
• The opioid epidemic: Mobilizing an academic health center to improve outcomes.

  2021cites this paper
• Understanding ED Buprenorphine Initiation for Opioid Use Disorder: A Guide for Emergency Nurses.

  2021cites this paper
• Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program

  2020cites this paper
• Harm-Reduction Interventions

  2020cites this paper
• A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada

  2020cites this paper
• Lessons Learned from the Response to the Human Immunodeficiency Virus Epidemic that Can Inform Addressing the Opioid Epidemic

  2020cites this paper
• Heroin‐assisted treatment of heroin‐addicted patients normalizes regulatory T cells but does not restore CD4+ T cell proliferation

  2020cites this paper
• Deconstructing the 'cheque effect': Short-term changes in injection drug use after receiving income assistance, and associated factors.

  2020cites this paper
• HIV knowledge and risk behaviors among drug users in three Vietnamese mountainous provinces

  2019cites this paper
• A Latent Class Analysis of HIV Risk Factors Among Men and Women with Opioid Use Disorder in Pre-trial Detention

  2019cites this paper
• Health in the European Union

  2019cites this paper
• Opioid use and misuse: health impact, prevalence, correlates and interventions

  2019cites this paper
• The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic

  2018cites this paper
• Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder

  2017cites this paper
• Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

  2017cites this paper
• High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.

  2017cites this paper
• The opioid crisis: past, present and future policy climate in Ontario, Canada

  2017cites this paper
• Heroin shortage in Coastal Kenya: A rapid assessment and qualitative analysis of heroin users' experiences.

  2016cites this paper
• Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.

  2016cites this paper
• The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study.

  2015cites this paper
• Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan

  2015cites this paper
• Preconception care: preventing and treating infections

  2014cites this paper
• Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.

  2014cites this paper
• Advancing Service Integration in Opioid Treatment Progams for the Care and Treatment of Hepatitis C Infection

  2014cites this paper
• Social Environmental Factors and Condom Use Among Female Injection Drug Users who are Sex Workers in China

  2014cites this paper
• Methadone-maintained patients in primary care have higher rates of chronic disease and multimorbidity, and use health services more intensively than matched controls

  2014cites this paper
• Harm Reduction at its Best: A case for Promoting Safe Injection Facilities

  2014cites this paper
• Combination Approaches to HIV Prevention

  2014cites this paper
• HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

  2014cites this paper
• Linking Heroin Users in China to Drug Treatment and Other Resources in the Community

  2013cites this paper
• Evaluation of Oxidative Markers, Apoptosis and Reproductive Efficiency in Heroin Addicted Rats

  2013cites this paper
• Systematic review research on needle/syringe programs and opiate substitution programs in low- and middle-income countries.

  2013cites this paper
• FACTORS ASSOCIATED WITH ADHERENCE TO METHADONE TREATMENT AMONG HEROIN USERS ATTENDING A METHADONE ASSISTED TREATMENT PROGRAM AT MUHIMBILI NATIONAL HOSPITAL

  2013cites this paper
• Drug trafficking, use, and HIV risk: The need for comprehensive interventions

  2012cites this paper
• The effectiveness of opioid maintenance treatment in prison settings: a systematic review.

  2012cites this paper
• Net financial benefits of averting HIV infections among people who inject drugs in Urumqi, Xinjiang, Peoples Republic of China (2005–2010)

  2012cites this paper
• Misconceptions toward methadone maintenance treatment (MMT) and associated factors among new MMT users in Guangzhou, China.

  2012cites this paper
• Evidence-based pharmacological treatment of substance use disorders and pathological gambling.

  2012cites this paper
• Effect Of Bacopa Monnieri On Morphine Dependence And Tolerance To Analgesia In Animal Models

  2012cites this paper
• ”Vi ska inte vara den där vita fläcken på kartan” - En fallstudie om etableringen av underhållsbehandling i Blekinge län

  2012cites this paper
• Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.

  2012cites this paper
• Sexual HIV Risk Behaviors in a Treatment-Refractory Opioid-Dependent Sample

  2012cites this paper
• Estrategias de intervención para disminuir la incidencia de VIH en usuarios de drogas intravenosas

  2012cites this paper
• Factors associated with methadone treatment among injection drug users in Bangkok, Thailand.

  2012cites this paper
• Immunosuppressive Effects of Opioids—Clinical Relevance

  2011cites this paper
• History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.

  2011cites this paper
• Opioid substitution therapy in resource-poor settings.

  2011cites this paper
• Commentary on Turner et al. (2011): Significant global scale-up of harm reduction interventions and pragmatic research approaches needed to prevent hepatitis C transmission.

  2011cites this paper
• Benefits of concurrent syringe exchange and substance abuse treatment participation.

  2011cites this paper
• A treatment reengagement intervention for syringe exchangers.

  2011cites this paper
• ECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addict.

  2011cites this paper
• Drogen- und Medikamentenabhängigkeit

  2011cites this paper
• The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.

  2011cites this paper
• Treatment retention in methadone maintenance programs in Indonesia: towards evidence-informed drug policy.

  2010cites this paper
• A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction.

  2010cites this paper
• The Edinburgh Addiction Cohort: recruitment and follow-up of a primary care based sample of injection drug users and non drug-injecting controls

  2010cites this paper
• Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment.

  2010cites this paper
• [HIV infection and injecting drug users: The urgency of reinvigorating harm-reduction programmes].

  2010cites this paper
• Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.

  2010cites this paper
• Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.

  2010cites this paper
• How Ukraine is tackling Europe’s worst HIV epidemic

  2010cites this paper
• Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand

  2010cites this paper
• Obsessive-Compulsive Anxiety Disorders

  2010cites this paper
• Incidence and risk for acute hepatitis C infection during imprisonment in Australia

  2010cites this paper
• Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

  2009cites this paper
• Review of Global Policy Architecture and Country Level Practice on HIV/AIDS and Drug Treatment

  2009cites this paper
• Expanded access to SEPs and other harm reduction measures in France.

  2009cites this paper
• Diacetylmorphine versus methadone for the treatment of opioid addiction.

  2009cites this paper
• L’intervention de type criminologique à l’aune de la Collaboration Cochrane

  2009cites this paper
• The Andalusian trial on heroin-assisted treatment: a 2 year follow-up.

  2009cites this paper
• Treatment, care and support for people co-infected with HIV and hepatitis C: a scoping review

  2009cites this paper
• Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial.

  2008cites this paper
• Severity of drug dependence, economic pressure and HIV-related risk behaviors among non-institutionalized female injecting drug users who are also sex workers in China.

  2008cites this paper
• Hepatitis Infection in the Treatment of Opioid Dependence and Abuse

  2008cites this paper
• Impact of methadone on drug use and risky sex in China.

  2008cites this paper
• Emerging HIV epidemics in muslim countries: Assessment of different cultural responses to harm reduction and implications for HIV control

  2007cites this paper
• Managing hepatitis C in users of illicit drugs

  2007cites this paper
• Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.

  2007cites this paper
• [Illegal drug users and risk factors for HIV and HCV infection].

  2007cites this paper
• Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection

  2006cites this paper
• Reason and rights in global drug control policy

  2005cites this paper
• La perspectiva de los usuarios sobre los tratamientos de mantenimiento con metadona: Una revisión centrada en la satisfacción con el tratamiento

  2005cites this paper